Effect of Tumor Necrosis Factor Inhibitors on Hip Involvement in Ankylosing Spondylitis: Is Structural Repair Possible?

被引：2
|
作者：
Slouma, Maroua [1 ,2 ,4 ]
Rouatbi, Feriel [1 ,2 ]
Ben Ammar, Lobna [2 ,3 ]
Gharsallah, Imen [1 ,2 ]
机构：
[1] Mil Hosp, Dept Radiol, Tunis, Tunisia
[2] Univ Tunis El Manar, Tunis, Tunisia
[3] Mil Hosp, Dept Internal Med, Tunis, Tunisia
[4] Mil Hosp, Dept Rheumatol, Tunis 1007, Tunisia
来源：
JOURNAL OF RHEUMATOLOGY | 2024年 / 51卷 / 01期
关键词：
PREVALENCE;
D O I：
10.3899/jrheum.2023-0446
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：104 / 105
页数：2
相关论文
共 50 条
  • [1] Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors
    Konsta, Maria
    Nurmohamed, Michael T.
    Iliopoulos, Alexios
    Sfikakis, Petros P.
    van Denderen, J. Christiaan
    Visman, Ingrid
    Sakelariou, Grigorios T.
    van der Horst-Bruinsma, Irene E.
    [J]. JOURNAL OF RHEUMATOLOGY, 2023, 50 (03) : 342 - 350
  • [2] Efficacy of Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis
    Dulgeroglu Erdogdu, Deniz
    Bal, Ajda
    Karaahmet, Ozgur
    Erkoc, Sibel
    Yalcin, Tugba
    Cakci, Aytul
    [J]. ARCHIVES OF RHEUMATOLOGY, 2014, 29 (04) : 257 - 266
  • [3] Therapeutic Controversies Tumor Necrosis Factor α Inhibitors in Ankylosing Spondylitis
    Song, I. H.
    Maksymowych, W. P.
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2012, 38 (03) : 613 - +
  • [4] The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis
    Lee, Suhwan
    Park, Yu Jeong
    Lee, Joo Yong
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (42)
  • [5] Effect of tumor necrosis factor inhibitors on spinal radiographic progression in patients with ankylosing spondylitis
    Jeong, Hyemin
    Eun, Yeong Hee
    Kim, In Young
    Park, Eun-Jung
    Kim, Hyungjin
    Lee, Jaejoon
    Jeon, Chan Hong
    Koh, Eun-Mi
    Cha, Hoon-Suk
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (05) : 1098 - 1105
  • [6] Cost–benefit analysis of tumor necrosis factor inhibitors in ankylosing spondylitis
    Rachel Murphy
    [J]. Nature Clinical Practice Rheumatology, 2006, 2 (5): : 237 - 238
  • [7] Benefits of tumor necrosis factor inhibitors for cardiovascular disease in ankylosing spondylitis
    Huang, Jin-Xian
    Lee, Yung-Heng
    Wei, James Cheng-Chung
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 112
  • [8] Economic evaluation of tumor necrosis factor inhibitors in the treatment of ankylosing spondylitis
    Parekh, H. H.
    Kamal, K. M.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A118 - A118
  • [9] TUMOR NECROSIS FACTOR ALPHA INHIBITORS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS
    Ubago, R.
    Castillo, M. A.
    Marin, R.
    Flores, S.
    Rodriguez, R.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A302 - A302
  • [10] The Impact of Tumor Necrosis Factor α Inhibitors on Radiographic Progression in Ankylosing Spondylitis
    Haroon, Nigil
    Inman, Robert D.
    Learch, Thomas J.
    Weisman, Michael H.
    Lee, MinJae
    Rahbar, Mohammad H.
    Ward, Michael M.
    Reveille, John D.
    Gensler, Lianne S.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (10): : 2645 - 2654
12345